학술논문
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial
Document Type
Article
Author
Middleton, G.; Palmer, D.H.; Greenhalf, W.; Ghaneh, P.; Jackson, R.; Cox, T.; Evans, A.; Shaw, V.E.; Costello, E.; Campbell, F.; Rawcliffe, C.; Neoptolemos, J.P.; Wadsley, J.; Valle, J.W.; Propper, D.; Wasan, H.; Falk, S.; Cunningham, D.; Coxon, F.; Ross, P.; Madhusudan, S.; Wadd, N.; Corrie, P.; Hickish, T.
Source
In: The Lancet Oncology . (The Lancet Oncology, 1 April 2017, 18(4):486-499)
Subject
Language
English
ISSN
14745488
14702045
14702045